NADELINFUSIONSSET FÜR INSULININFUSION
European patent · EP3744367 · In force
Register entry
- Publication number
- EP3744367
- Application number
- EP19205345
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Oct 25, 2019
- Published
- Dec 2, 2020
- Granted
- Sep 17, 2025
- Protection ends at the latest
- Oct 24, 2039
- Next annual fee due
- Oct 31, 2026
- IPC classes
- A61M 5/158 (2006.01)A61M 5/142 (2006.01)A61M 5/162 (2006.01)A61M 5/14 (2006.01)A61M 39/10 (2006.01)
- Priority
- KR 20190063177 29.05.2019
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jul 29, 2026
Change
Published in Swissreg on 29.07.2026
- Dec 1, 2025
Next annual fee due on
- Next annual fee due on
- 31.10.2025 → 31.10.2026
Published in Swissreg on 01.12.2025
- Oct 28, 2025
Agent entered
- Representative
- MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex
Published in Swissreg on 28.10.2025
- Sep 17, 2025
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 17.09.2025
Parties
Inventor
CHOI, Soo Bong
Seoul, KR
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.